MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0008433
Sanzyme Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹153.25 Cr
▼ 27% YoY
Net profit · FY 2025
₹12.5 Cr
Net margin 8.2%
EBITDA · FY 2025
-₹31.82 Cr
EBITDA margin -20.8%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.76 Cr
Issued & subscribed
Open charges
₹77 Cr
Satisfied ₹237.14 Cr
Company age
57 yrs
Est. 1969
Employees · EPFO
193
Provident fund records
About Sanzyme Private Limited
Data last updated:
Sanzyme Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 1969 and has been in existence for over 57 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24235TG1969PTC001282. Its GSTIN is 36AAACU2692R1ZM (Telangana). The company holds 21 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.76 Cr. It was formerly known as Uni-Sankyo Ltd and Sanzyme Limited. It is led by directors including Jay Soman (Managing Director) and Subrahmanyaprasad Venkata Satyasurya Kompella (Whole-Time Director).
Its last annual general meeting (AGM) was held on 18 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹153.25 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹12.5 Cr (net margin 8.2%) and EBITDA of -₹31.82 Cr (EBITDA margin -20.8%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 5% over five years.
The company has about 193 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Sanzyme. As per MCA filings, the company has open charges of ₹77 Cr and satisfied charges of ₹237.14 Cr on record. Court records list 82 cases involving the company, including 61 filed by the company and 21 filed against it; 16 cases are pending. The company has 13 deals on record (12 secondary share transfers, 1 acquisition); the latest was in March 2023. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 2 smaller; the largest is Wardex Pharmaceuticals Private Limited with revenue of ₹158.1 Cr.
Sanzyme Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0008433). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanzyme.com.
Company details
CIN U24235TG1969PTC001282
Registration Number 001282
Incorporation Date 05 August 1969
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0008433
Name history
Sanzyme has undergone 2 name changes throughout its history. The company was previously known as Uni-Sankyo Ltd, and Sanzyme Limited. The current legal name is Sanzyme Private Limited.
| Company Name | Status |
|---|---|
| Sanzyme Private Limited | Current |
| Uni-Sankyo Ltd | Previous |
| Sanzyme Limited | Previous |
CIN history
Sanzyme has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24235TG1969PTC001282, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24235TG1969PTC001282 | Current |
| U24235TG1969PLC001282 | Previous |
| U24235AP1969PLC001282 | Previous |
| U99999AP1969PLC001282 | Previous |
Key People
Jay Soman Managing Director Subrahmanyaprasad Venkata Satyasurya Kompella Whole-Time Director Raunak Jay Soman Director Recognitions & Rankings of Sanzyme
Contact details
Sanzyme Private Limited's registered office is in Hyderabad, Telangana. Its website is sanzyme.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2nd Floor Sattva Signature Tower, #8 – 2 – 472/1/A/B/Sf – 3 Road No. 1, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanzyme Private Limited, buy the company report.
Comprehensive company report
Sanzyme Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sanzyme operates one associated brand: Sanzyme. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Human-derived gonadotropins and sex hormones are manufactured for fertility applications. | sanzyme.com |
Business activity
The main business activity of Sanzyme is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanzyme Private Limited, buy the company report.
Financials of Sanzyme Private Limited
FY 2025 filings availableSanzyme Private Limited reported revenue of ₹153.25 Cr (down 27% YoY) for FY 2025.
Revenue · FY 2025
₹153.25 Cr ▼ 27%
Net profit · FY 2025
₹12.5 Cr margin 8.2%
EBITDA · FY 2025
-₹31.82 Cr margin -20.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 27%
3 years · compounded
▲ 31%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 27% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹153.25 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹31.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -20.8% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanzyme Private Limited, buy the company report.
Board of directors of Sanzyme Private Limited
Sanzyme has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raunak Jay Soman | Director | 28 Sep 2021 | 5 Years 0 Months | Current |
| Dhruv Jay Soman | Director | 11 Jun 2020 | 6 Years 4 Months | Current |
| Arun Rao Akinepally Also directs: Akin Laboratories Pvt Ltd | Director | 16 Mar 2012 | 14 Years 7 Months | Current |
| Subrahmanyaprasad Venkata Satyasurya Kompella Also directs: Plantus Private Limited | Whole-Time Director | 27 Oct 2017 | 8 Years 11 Months | Current |
| Jay Soman Also directs: Plantus Private Limited, Sanzyme Biologics Private Limited | Managing Director | 01 Jun 2010 | 16 Years 4 Months | Current |
| Surapaneni Sree Rama Koteswara Rao | Director | 19 Aug 1992 | 34 Years 2 Months | Current |
Peer comparison
Sanzyme Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India | |||
| Nitin Lifesciences Limited | ₹157.19 Cr (FY 2025) | 7.0% | Paonta Sahib, Himachal Pradesh, India | |||
| Wings Pharmaceuticals Pvt Ltd | ₹155.72 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Combitic Global Caplet Private Limited | ₹154.55 Cr (FY 2025) | 37.0% | New Delhi, Delhi, India | |||
| Medico Remedies Limited | ₹153.63 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Sanzyme Private Limitedthis company | ₹153.25 Cr (FY 2025) | ₹12.5 Cr | 8.2% | -27.0% | 193 | Hyderabad, Telangana, India |
| D K Pharma Chem Private Limited | ₹153.13 Cr (FY 2024) | -33.0% | Badlapur, Maharashtra, India | |||
| Hema Laboratories Pvt Ltd | ₹152.89 Cr (FY 2025) | 0.0% | Wadhwancity, Gujarat, India |
To see the full peer comparison of Sanzyme Private Limited, buy the company report.
Auditor
Sanzyme Private Limited is audited by K. S. RAO &Co for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. S. RAO &Co | FY 2025 | 003109S |
Shareholding
The shareholding of Sanzyme Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanzyme Private Limited, buy the company report.
Charges & borrowings
Open charges
₹77 Cr
Satisfied charges
₹237.14 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2026 | 101302292 | Axis Bank Limited | ₹28 Cr | Open | |
| 25 Feb 2026 | 101278270 | Standard Chartered Bank | ₹12 Cr | Open | |
| 24 Nov 2016 | 100064608 | Others | ₹37 Cr | Open | |
| 28 Nov 2016 | 100064501 | Others | ₹46.54 Cr | Satisfied | |
| 15 Sep 2014 | 10520383 | Citi Bank N.A. | ₹10 Cr | Satisfied |
To see the full charge records of Sanzyme Private Limited, buy the company report.
Total charge records: 49 View all charges
Deals & funding
Sanzyme Private Limited has 13 deals on record (12 secondary share transfers, 1 acquisition); the latest was in March 2023.
Total deals
13
Secondary share transfers
12
Acquisition
1
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2022 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Jan 2022 | Acquisition | ₹628 Cr | Buyer: J B Chemicals and Pharmaceuticals Limited Seller: Sanzyme Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
| Dec 2008 | Secondary share transfer | Undisclosed | Buyer: Daiichi Sankyo India Pharma Private Limited , 3 individuals Seller: Sankyo Company Limited, 3 individuals |
To see the full deal history of Sanzyme Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sanzyme Private Limited has 82 court cases on record: 61 filed by Sanzyme, 21 filed against it. 16 cases are pending and 66 are disposed.
Total cases
82
Filed by the company
61
Filed against the company
21
Pending
16
Disposed
66
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 58 | 16 | 15 |
| High courts | 24 | 5 | 1 |
Cases on record (5 of 82)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S Being Sure Life Sciences Pvt Ltd | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed by the company against M/S Being Sure Life Sciences Pvt Ltd | Disposed |
| High Court for State of Telangana | Writ petition | Filed against the company by M/S Pochiraju Industries Ltd., Tamilnadu | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (MVOP) | Filed against the company by an individual | Pending |
| District court, Hanumakonda, Telangana | Criminal complaint | Filed against the company by State of Telangana Through the Drugs Inspector Drugs Control Administration Hanumakonda District | Pending |
To see the full case history of Sanzyme Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sanzyme Private Limited was last rated by Crisil on 25 Oct 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 25 Oct 2019 |
To see the full credit ratings and regulatory alerts of Sanzyme Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanzyme Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Sanzyme has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Plantus Private Limited | U24100TG2010PTC068602 |
To see the full group structure of Sanzyme Private Limited, buy the company report.
Employees & EPFO
Sanzyme Private Limited has a workforce of 193 employees on its EPFO records as of Oct 09, 2025, across 1 active EPFO establishment.
Employee count
193
Active EPFO establishments
1
Employee growth
18.4%
GST
Sanzyme has 21 GST registrations: 2 active and 19 cancelled or inactive.
Total GSTINs
21
Active
2
Cancelled / inactive
19
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACU2692R1ZM | Telangana | Active | 01 Jul 2017 |
| 32AAACU2692R1ZU | Kerala | Active | 28 Nov 2018 |
To see the full GST registrations and return filing status of Sanzyme Private Limited, buy the company report.
Recent activity
Sanzyme Private Limited has 13 board changes on record since 1992: 6 appointments and 7 cessations. The latest: Kona Devaprabhakara Murthy ceased to be Company Secretary on 16 Apr 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 28.00 Cr with Charge ID 101302292 was registered on 27 May 2026.
Charges
A charge with Standard Chartered Bank amounted to Rs. 12.00 Cr with Charge ID 101278270 was registered on 25 Feb 2026.
AGM
Sanzyme Private Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Ceased
Kona Devaprabhakara Murthy ceased to be Company Secretary.
Filing
Sanzyme Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 37.00 Cr registered on 24 Nov 2016 with Charge ID 100064608 was modified on 29 May 2023.
Appointed
Raunak Jay Soman was appointed as Director.
Ceased
Parag Chandulal Mehta ceased to be Director.
Appointed
Dhruv Jay Soman was appointed as Director.
Charges
A charge registered on 28 Nov 2016 via Charge ID 100064501 with Others was fully satisfied on 20 May 2019.
Appointed
Subrahmanyaprasad Venkata Satyasurya Kompella was appointed as Whole-Time Director.
Charges
A charge with Others of Rs. 46.54 Cr registered on 28 Nov 2016 with Charge ID 100064501 was modified on 15 Sep 2017.
120 earlier events are in the company report.
Frequently asked questions
Sanzyme is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 1969 (57+ years old) and is registered under CIN U24235TG1969PTC001282.
Sanzyme has 6 current directors:
- Jay Soman - Managing Director
- Subrahmanyaprasad Venkata Satyasurya Kompella - Whole-Time Director
- Raunak Jay Soman - Director
- Dhruv Jay Soman - Director
- Arun Rao Akinepally - Director
- Surapaneni Sree Rama Koteswara Rao - Director
The latest financial statements of Sanzyme on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanzyme is 36AAACU2692R1ZM, registered in Telangana. The company has 21 GST registrations in all, of which 2 are active and 19 are cancelled or inactive. Other active GSTINs include 32AAACU2692R1ZU (Kerala).
The CIN (Corporate Identification Number) of Sanzyme is U24235TG1969PTC001282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanzyme has 82 court cases on record: 61 filed by the company and 21 filed against it. 16 are pending. Most are in the district courts.
Sanzyme was incorporated on 05 August 1969, making it 57+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sanzyme has 13 deals on record (12 secondary share transfers, 1 acquisition); the latest was in March 2023.
The peers of Sanzyme by revenue are Wardex Pharmaceuticals Private Limited, Nitin Lifesciences Limited, Wings Pharmaceuticals Pvt Ltd, Combitic Global Caplet Private Limited, Medico Remedies Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kona Devaprabhakara Murthy ceased to be Company Secretary on 16 Apr 2025. Raunak Jay Soman was appointed as Director on 28 Sep 2021. Parag Chandulal Mehta ceased to be Director on 24 Aug 2021. Sanzyme has 13 board changes on record in total.
Yes, Sanzyme is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0008433).